Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ): Price and Financial Metrics

Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ): $110.58

2.91 (-2.56%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

B

Add JAZZ to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#2 of 360

in industry

JAZZ Price/Volume Stats

Current price $110.58 52-week high $147.14
Prev. close $113.49 52-week low $110.42
Day low $110.42 Volume 431,400
Day high $113.10 Avg. volume 615,530
50-day MA $121.19 Dividend yield N/A
200-day MA $126.25 Market Cap 6.97B

JAZZ Stock Price Chart Interactive Chart >


Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) Company Bio


Jazz Pharmaceuticals is an international biopharmaceutical company with a diverse portfolio of products and/or product candidates with a focus in the areas of sleep and hematology/oncology. The company was founded in 2003 and is based in Dublin, Ireland.


JAZZ Latest News Stream


Event/Time News Detail
Loading, please wait...

JAZZ Latest Social Stream


Loading social stream, please wait...

View Full JAZZ Social Stream

Latest JAZZ News From Around the Web

Below are the latest news stories about JAZZ PHARMACEUTICALS PLC that investors may wish to consider to help them evaluate JAZZ as an investment opportunity.

7 Growth Stocks Poised to Thrive in a Post-Fed Pivot World

With the Federal Reserve previously engaged in a bitter – and seemingly, at times desperate – struggle against blisteringly hot inflation, the narrative for growth stocks to buy now frankly didn’t resonate very well with many investors.

Josh Enomoto on InvestorPlace | December 29, 2023

Jazz Pharmaceuticals' (JAZZ) PTSD Drug Misses Study Goals

After a mid-stage study fails to show any improvement in its primary or secondary endpoints, Jazz (JAZZ) plans to scrap the development of its PTSD drug.

Yahoo | December 22, 2023

Jazz Pharmaceuticals' Post-Traumatic Stress Disorder Drug Disappoints In Mid-Stage Study

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced top-line results from the Phase 2 trial of JZP150, an investigational small molecule selective fatty acid amide hydrolase (FAAH) inhibitor, on efficacy and safety in adults with post-traumatic stress disorder (PTSD). The trial did not meet the primary endpoint. There was not a statistically significant decrease in PTSD symptom severity as measured by the Clinician-Administered PTSD Scale between JZP150 (4mg or 0.3mg) compared to placebo from base

Yahoo | December 22, 2023

Jazz Pharmaceuticals Provides Update on Phase 2 Trial of Investigational JZP150 in Adult Patients with Post-Traumatic Stress Disorder

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced top-line results from the Phase 2 trial (NCT05178316) evaluating JZP150, an investigational small molecule selective fatty acid amide hydrolase (FAAH) inhibitor, on efficacy and safety in adults with post-traumatic stress disorder (PTSD). The trial did not meet the primary endpoint. There was not a statistically significant decrease in total PTSD symptom severity as measured by the Clinician Administered PTSD Scale (CAPS-5) between JZP150 (

Yahoo | December 21, 2023

Jazz Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will webcast its corporate presentation at the 42nd Annual J.P. Morgan Healthcare Conference. Bruce Cozadd, chairman and chief executive officer, will provide an overview of the company and a business and financial update on Monday, January 8, 2024, at 2:15 p.m. PST / 10:15 p.m. GMT.

Yahoo | December 20, 2023

Read More 'JAZZ' Stories Here

JAZZ Price Returns

1-mo -8.54%
3-mo -7.18%
6-mo -16.59%
1-year -24.01%
3-year -34.53%
5-year -13.39%
YTD -10.10%
2023 -22.79%
2022 25.05%
2021 -22.81%
2020 10.56%
2019 20.43%

Continue Researching JAZZ

Here are a few links from around the web to help you further your research on Jazz Pharmaceuticals plc's stock as an investment opportunity:

Jazz Pharmaceuticals plc (JAZZ) Stock Price | Nasdaq
Jazz Pharmaceuticals plc (JAZZ) Stock Quote, History and News - Yahoo Finance
Jazz Pharmaceuticals plc (JAZZ) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!